A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

Clinical trial NCT01328041 · COMPLETED

Trial details

NCT number: NCT01328041
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2011-05-01
Primary completion: 2012-05-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.